跳至主要内容
临床试验/CTRI/2018/04/012912
CTRI/2018/04/012912暂停未知

A retrospective observational safety to evaluate safety of Classically prepared Ayurvedic Herbometallic compounds in hetrogenous group of chronically ill patients treated with herbometallic compounds

Rasayani Cancer Clinics Pune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
暂停
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male and Female patients with age 18-50 years.
  • Patient consuming herbometallic formulation since from more than three months

排除标准

  • 1.patient suffering from renal disorders
  • 2. Patient suffering from hepatic disorders
  • 3. Patient suffering from diabeties and hypertension.

研究者

发起方
Rasayani Cancer Clinics Pune

相似试验